Core Viewpoint - Global Medical (02666.HK) has received approval from the China Securities Regulatory Commission to issue a maximum of RMB 2 billion in domestic perpetual corporate bonds aimed at qualified investors, with a remaining quota of RMB 1.2 billion as of the announcement date [1] Group 1: Company Financials - The company plans to issue bonds in tranches, with the total principal amount for this issuance not exceeding RMB 850 million [1] - The basic term of the corporate bonds is set at 3 years [1] - As of August 5, 2025, Global Medical's stock closed at HKD 6.2, down 1.27%, with a trading volume of 18.6425 million shares and a turnover of HKD 115 million [1] Group 2: Market Position - Global Medical has a market capitalization of HKD 11.879 billion, ranking 5th in the medical services sector [1] - Key financial metrics compared to industry averages are as follows: - Return on Equity (ROE): 12.68% vs. industry average of -2.25% [1] - Market capitalization: HKD 11.879 billion vs. industry average of HKD 6.855 billion [1] - Revenue: HKD 13.663 billion vs. industry average of HKD 3.704 billion [1] - Net Profit Margin: 16.53% vs. industry average of -841.37% [1] - Gross Margin: 33.61% vs. industry average of 36.84% [1] - Debt Ratio: 73.42% vs. industry average of 73.74% [1]
环球医疗(02666.HK)附属拟发行不超8.5亿元公司债券